Pfizer Inc

VANGUARD GROUP INC PFE

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

541,346,182

Value ($000)

13,479,520

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	13,479,520	0.2%	541,346,182	12/31/2025
2025 Q3	11/7/2025	13,614,347	0.2%	534,315,020	9/30/2025
2025 Q2	8/11/2025	12,928,730	0.2%	533,363,457	6/30/2025
2025 Q1	5/9/2025	13,257,004	0.2%	523,165,127	3/31/2025
2024 Q4	2/11/2025	13,756,738	0.2%	518,535,151	12/31/2024
2024 Q3	11/13/2024	14,940,271	0.3%	516,249,875	9/30/2024
2024 Q2	8/13/2024	14,309,057	0.3%	511,403,040	6/30/2024
2024 Q1	5/10/2024	14,076,295	0.3%	507,253,881	3/31/2024
2023 Q4	3/11/2024	14,582,638	0.3%	506,517,466	12/31/2023
2023 Q3	12/18/2023	16,808,165	0.4%	506,727,929	9/30/2023
2023 Q2	8/14/2023	18,636,891	0.4%	508,094,084	6/30/2023
2023 Q1	7/14/2023	20,743,045	0.5%	508,407,975	3/31/2023
2022 Q4	2/10/2023	25,703,840	0.7%	501,636,220	12/31/2022
2022 Q3	11/14/2022	21,599,270	0.6%	493,584,761	9/30/2022
2022 Q2	8/12/2022	25,609,178	0.7%	488,445,127	6/30/2022
2022 Q1	5/13/2022	24,801,210	0.6%	479,065,273	3/31/2022
2021 Q4	2/14/2022	27,474,484	0.6%	465,274,925	12/31/2021
2021 Q3	11/12/2021	19,782,119	0.5%	459,942,303	9/30/2021
2021 Q2	8/13/2021	17,864,934	0.4%	456,203,630	6/30/2021
2021 Q1	5/14/2021	16,336,618	0.4%	450,914,119	3/31/2021
2020 Q4	2/12/2021	16,489,361	0.5%	447,958,747	12/31/2020
2020 Q3	11/16/2020	16,554,477	0.5%	451,075,687	9/30/2020
2020 Q2	8/14/2020	14,940,428	0.5%	456,893,858	6/30/2020
2020 Q1	5/15/2020	15,078,916	0.6%	461,976,599	3/31/2020
2019 Q4	2/14/2020	17,629,402	0.6%	449,959,230	12/31/2019
2014 Q2	8/11/2014	9,734,583	0.8%	327,984,566	6/30/2014
2014 Q1	5/13/2014	10,356,486	0.9%	322,431,054	3/31/2014
2013 Q4	2/12/2014	9,780,973	0.9%	319,326,615	12/31/2013